Immuneering CORP Schedule 13G passive stakes

Benjamin J. Zeskind, a key insider at Immuneering Corporation, has reported beneficial ownership of 6.6% of the company's Class A common stock as of December 31, 2025.

Empery Asset Management and Ryan M. Lane report a 4.99% beneficial ownership stake in Immuneering Corp's Class A Common Stock, including warrants.

Empery Asset Management, LP and its managing members reported a beneficial ownership of 8.83% of Immuneering Corp.'s Class A Common Stock.

FMR LLC and Abigail P. Johnson disclose a 14.5% beneficial ownership in Immuneering Corp's Class A Common Stock as of September 30, 2025.

HBM Healthcare Investments (Cayman) Ltd. has reported a passive 5.7% beneficial ownership stake in Immuneering Corp, holding 3,646,304 shares of Class A Common Stock.

Benjamin J. Zeskind has filed an amended Schedule 13G, reporting a 12.8% beneficial ownership stake in Immuneering Corporation's Class A common stock as of December 31, 2024.